BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• RedHill Biopharma Ltd. To Present At Jefferies and Co. 2014 Global Healthcare Conference

  June 2, 2014

   · 

  1 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Announces Initial Data from Phase 2 Trial Of Ponatinib In Patients With Gastrointestinal Stromal Tumors

  June 2, 2014

   · 

  1 min read
• Drug Development

  Puma Biotechnology Announces Presentation Of Positive PB272 Phase II Data At The 2014 ASCO Annual Meeting

  June 2, 2014

   · 

  1 min read
• Biotech Beach

  Zogenix, Inc. Officers To Report Withholding Of Shares

  June 2, 2014

   · 

  1 min read
• Drug Development

  The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy

  June 2, 2014

   · 

  7 min read
• Drug Development

  Seattle Genetics, Inc. Presents Data from Phase 1 Clinical Trial Of Antibody-Drug Conjugate (ADC) SGN-CD19A In Non-Hodgkin Lymphoma At American Society of Clinical Oncology Annual Meeting

  June 2, 2014

   · 

  1 min read
• Business

  Memorial Medical Center And Quest Diagnostics Inc. Partner To Advance Precision Medicine In Cancer Diagnosis And Treatment

  June 2, 2014

   · 

  6 min read
• Drug Development

  Argos Therapeutics, Inc. Release: Treatment With AGS-003 And Sunitinib Associated With Doubling Of Expected Survival In Patients With Unfavorable Risk Metastatic Renal Cell Carcinoma (mRCC)

  June 2, 2014

   · 

  1 min read
• Drug Development

  Immunomedics, Inc. Reports IMMU-130 Is Active In Patients With Irinotecan-Refractory Colorectal Cancer

  June 2, 2014

   · 

  1 min read
• Dutch Cancer Patients To Benefit From Erasmus Medical Center Daniel den Hoed Cancer Center’s New Treatment Technology

  June 2, 2014

   · 

  2 min read